ID16666A - BENTUK SEDIAAN PADAT SISAPRID DENGAN PELEPASAN SEGERA YANG TIDAK TERGANTUNG PADA pH - Google Patents

BENTUK SEDIAAN PADAT SISAPRID DENGAN PELEPASAN SEGERA YANG TIDAK TERGANTUNG PADA pH

Info

Publication number
ID16666A
ID16666A IDP971336A ID971336A ID16666A ID 16666 A ID16666 A ID 16666A ID P971336 A IDP971336 A ID P971336A ID 971336 A ID971336 A ID 971336A ID 16666 A ID16666 A ID 16666A
Authority
ID
Indonesia
Prior art keywords
sisaprid
provisions
don
depend
solid
Prior art date
Application number
IDP971336A
Other languages
English (en)
Inventor
Paul Marie Victor Gilis
Guido Franciscus Smans
Guido Jozef Maria Gijs
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID16666A publication Critical patent/ID16666A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDP971336A 1996-04-23 1997-04-22 BENTUK SEDIAAN PADAT SISAPRID DENGAN PELEPASAN SEGERA YANG TIDAK TERGANTUNG PADA pH ID16666A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201078 1996-04-23

Publications (1)

Publication Number Publication Date
ID16666A true ID16666A (id) 1997-10-30

Family

ID=8223900

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971336A ID16666A (id) 1996-04-23 1997-04-22 BENTUK SEDIAAN PADAT SISAPRID DENGAN PELEPASAN SEGERA YANG TIDAK TERGANTUNG PADA pH

Country Status (23)

Country Link
US (1) US6030988A (id)
JP (1) JPH10510559A (id)
KR (1) KR100204115B1 (id)
CN (1) CN1216467A (id)
AR (1) AR006790A1 (id)
AT (1) ATE220543T1 (id)
AU (1) AU720582B2 (id)
BG (1) BG102812A (id)
BR (1) BR9708585A (id)
CA (1) CA2201264C (id)
CZ (1) CZ332598A3 (id)
DE (1) DE69713948D1 (id)
EA (1) EA000804B1 (id)
EE (1) EE03552B1 (id)
ID (1) ID16666A (id)
IL (1) IL125979A0 (id)
NO (1) NO984016L (id)
NZ (1) NZ331705A (id)
PL (1) PL328917A1 (id)
SK (1) SK144698A3 (id)
TR (1) TR199802139T2 (id)
WO (1) WO1997039744A1 (id)
ZA (1) ZA973449B (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20030138485A1 (en) * 1998-01-14 2003-07-24 Daiichi Pharmaceutical Co., Ltd. Disintegrant
EP1004305B1 (en) * 1998-04-20 2011-09-28 Eisai R&D Management Co., Ltd. Stabilized compositions containing benzimidazole-type compounds
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
US6353005B1 (en) * 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
DE60036014T2 (de) 1999-10-20 2008-04-30 Eisai R&D Management Co., Ltd. Methode zur stabilisierung von benzimidazol-verbindungen
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US7714006B1 (en) 2001-12-03 2010-05-11 King Pharmaceuticals Research & Development, Inc. Methods of modifying the bioavailability of metaxalone
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
DE10164510A1 (de) 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
GB2390541A (en) * 2002-07-12 2004-01-14 Reckitt Benckiser Healthcare Medicinal composition comprising fibre or saccharide bulking agents
AU2003276688A1 (en) * 2002-09-02 2004-03-19 Sun Pharmaceutical Industries Limited Pharmaceutical composition of metaxalone with enhanced oral bioavailability
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
TWI398273B (zh) * 2003-07-18 2013-06-11 Santarus Inc 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
AU2005249367A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
ES2381495T3 (es) * 2005-05-26 2012-05-28 Teva Women's Health, Inc. Formas de dosificación oral que comprenden progesterona y métodos para fabricar y usar las mismas
CN1935264B (zh) * 2005-09-23 2010-05-05 北京德众万全医药科技有限公司 一种用于缓控释片的含有hpmc的新型复合辅料
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
TW200843802A (en) * 2007-02-09 2008-11-16 Drugtech Corp Compositions for improving gastrointestinal nutrient and drug absorption
CN104352465B (zh) * 2014-11-17 2017-04-12 成都新恒创药业有限公司 一种不含二氧化硅的琥珀酸普芦卡必利药物组合物及其制备方法
JP7222063B2 (ja) 2018-07-12 2023-02-14 四川海思科制▲薬▼有限公司 縮合三環性γ－アミノ酸誘導体の組成物及びその調製
CN109394711A (zh) * 2018-11-06 2019-03-01 威海贯标信息科技有限公司 一种酒石酸西尼必利片组合物
WO2023242796A1 (en) * 2022-06-15 2023-12-21 Varoli Giovan Battista Box for the supply of food products for dysphagic users

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
EP1145715A3 (en) * 1992-07-07 2004-05-19 Sepracor Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
WO1994001111A1 (en) * 1992-07-07 1994-01-20 Sepracor Inc. Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
EP0707492A1 (en) * 1993-07-06 1996-04-24 Merck & Co. Inc. H 2? antagonist-gastrointestinal motility agent combinations
ES2136157T3 (es) * 1994-03-01 1999-11-16 Gerhard Gergely Producto granular o comprimido que contiene un sistema efervescente y una sustancia farmaceutica activa, asi como un procedimiento para su preparacion.
CH686865A5 (de) * 1994-06-15 1996-07-31 Gergely Gerhard Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
US6030988A (en) 2000-02-29
BR9708585A (pt) 1999-08-03
KR100204115B1 (ko) 1999-06-15
AU720582B2 (en) 2000-06-08
EA000804B1 (ru) 2000-04-24
NO984016D0 (no) 1998-09-01
KR970069038A (ko) 1997-11-07
CN1216467A (zh) 1999-05-12
AR006790A1 (es) 1999-09-29
SK144698A3 (en) 1999-05-07
CA2201264A1 (en) 1997-10-23
NZ331705A (en) 1999-11-29
NO984016L (no) 1998-12-23
IL125979A0 (en) 1999-04-11
EE9800269A (et) 1999-02-15
TR199802139T2 (xx) 1999-03-22
AU2290497A (en) 1997-11-12
ATE220543T1 (de) 2002-08-15
DE69713948D1 (de) 2002-08-22
BG102812A (en) 1999-05-31
ZA973449B (en) 1998-10-22
EE03552B1 (et) 2001-12-17
CA2201264C (en) 1999-08-10
PL328917A1 (en) 1999-03-01
JPH10510559A (ja) 1998-10-13
WO1997039744A1 (en) 1997-10-30
EA199800861A1 (ru) 1999-02-25
CZ332598A3 (cs) 1999-01-13

Similar Documents

Publication Publication Date Title
ID16666A (id) BENTUK SEDIAAN PADAT SISAPRID DENGAN PELEPASAN SEGERA YANG TIDAK TERGANTUNG PADA pH
DE69716101D1 (de) Wasserundurchlässige gesichtsmaske
DE69625586D1 (de) Gegossener Flächenhaftverschluss
DE69721533D1 (de) Bekleidungsstück
ID18829A (id) Komposisi sabun yang dicetak
EP0960191A4 (en) COMPOSITIONS AND METHOD FOR USE OF DEFENSIN
IS5419A (is) Vatnshreinsunar- og vatnsmiðlunartæki
DE69918206D1 (de) Dispositif d'alimentation et de traitement de feuilles
BR9502407A (pt) Composição lubrificante e concetrado
FR2723412B1 (fr) Marquage des garnitures de friction
PL326604A1 (en) Derivatives of 5"-dezoxy-cytidin
EP1056457A4 (en) S-LANZOPRAZOL COMPOSITIONS AND METHODS
IT1301931B1 (it) Collegamento d'alberi
FR2769492B1 (fr) Prothese d'oreille moyenne
EP1004303A4 (en) COMPOSITION TO AVOID RISK FACTORS IN SPORTS TRAINING
MA24411A1 (fr) Muteines de l'obesite
MA23679A1 (fr) Circuit convertisseur d'alimentation
HUP9700816A3 (en) 3(r)-3-amino-4-carboxy-butiraldehyde derivatives inhibiting release of interleukin-1-beta
IT244003Y1 (it) Tenuta d'albero
DE69626426D1 (de) Wasserdichte atmungsaktive bekleidung
FR2748717B1 (fr) Module d'habitation autonome flottant
ITRG940008V0 (it) Depuratore d'aria ad acqua
FR2727183B1 (fr) Bague d'etancheite
KR19980027998U (ko) 캠코더의 ccd ic의 브라케트
FR2756310B1 (fr) Montant auxiliaire d'echafaudage